Therefore, in the present study, we wanted to explore the role of ATG7 in NAFLD associated with obesity by studying the ATG7 mRNA and the protein expression of ATG7 in the liver of normal-weight subjects (the control group) and a cohort with MO and different degrees of liver involvement. This evidence concerns the gene ATG7 and metabolic dysfunction-associated steatotic liver disease.